Risk factors for massive hemorrhage after radical nephrectomy and removal of venous tumor thrombus

  • Dong LAN ,
  • Zhuo LIU ,
  • Yu-xuan LI ,
  • Guo-liang WANG ,
  • Xiao-jun TIAN ,
  • Lu-lin MA ,
  • Shu-dong ZHANG ,
  • Hong-xian ZHANG
Expand
  • 1. Department of Urology, Peking University Third Hospital, Beijing 100191, China
    2. Department of Urology, Guang'an People's Hospital, Guang'an 638500, Sichuan, China

Received date: 2023-03-25

  Online published: 2023-10-09

Abstract

Objective: To investigate and analyze the risk factors of massive hemorrhage in patients with renal cell carcinoma and venous tumor thrombus undergoing radical nephrectomy and removal of venous tumor thrombus. Methods: From January 2014 to June 2020, 241 patients with renal cancer and tumor thrombus in a single center of urology at Peking University Third Hospital were retrospectively analyzed. All patients underwent radical nephrectomy and removal of venous tumor thrombus. The relevant preoperative indicators, intraoperative conditions, and postoperative data were statistically analyzed by using statistical software of SPSS 18.0. The main end point of the study was intraoperative bleeding volume greater than 2 000 mL. Logistic regression analysis was used to determine the relevant influencing factors. First, single factor Logistic regression was used for preliminary screening of influencing factors, and variables with single factor Logistic regression analysis P < 0.05 were included in multivariate Logistic regression. In all statistical analyses, P < 0.05 is considered statistically significant. Results: Among the 241 patients included, there were 60 cases of massive hemorrhage, 48 males and 12 females, with a median age of 62 years. The number of non-massive hemorrhage was 181. There were 136 males and 45 females, with a median age of 59 years. Univariate analysis showed that the clinical symptoms (both systemic and local symptoms, OR 2.794, 95%CI 1.087-7.181, P=0.033), surgical approach (open surgery, OR 9.365, 95%CI 4.447-19.72, P < 0.001), Mayo grade (Mayo 3-4, OR 5.257, 95%CI 2.806-10.886, P < 0.001), American Society of Anesthesiologists (ASA) score (ASA level 3, OR 2.842, 95%CI 1.338-6.036, P=0.007), preoperative hemoglobin (OR 0.978, 95%CI 0.965-0.991, P=0.001), preoperative platelet count (OR 0.996, 95%CI 0.992-1.000, P=0.037), maximum tumor thrombus width (OR 1.061, 95%CI 1.033-1.091, P < 0.001), Complicated with bland thrombus (OR 4.493, 95%CI 2.264-8.915, P < 0.001), adrenalectomy (OR 3.101, 95%CI 1.614-5.958, P=0.001), segmental resection of the inferior vena cava (OR 2.857, 95%CI 1.395-5.852, P=0.004). There was a statistically significant difference in these aspects(P < 0.05). Multivariate Logistic regression analysis showed that there was a statistically significant difference in surgical approach (open surgery, OR 6.730, 95%CI 2.947-15.368;P < 0.001), Mayo grade (Mayo 3-4, OR 2.294, 95%CI 1.064-4.948, P=0.034), Complicated with bland thrombus (OR 3.236, 95%CI 1.492-7.020, P=0.003). Conclusion: Combining the results of univariate and multivariate Logistic regression analysis, the surgical approach, Mayo grade, and tumor thrombus combined with conventional thrombus were associated risk factors for massive hemorrhage during surgery for renal cell carcinoma with tumor thrombus. Patients who undergo open surgery, high Mayo grade, and tumor thrombus combined with conventional thrombus are at a relatively higher risk of massive hemorrhage.

Cite this article

Dong LAN , Zhuo LIU , Yu-xuan LI , Guo-liang WANG , Xiao-jun TIAN , Lu-lin MA , Shu-dong ZHANG , Hong-xian ZHANG . Risk factors for massive hemorrhage after radical nephrectomy and removal of venous tumor thrombus[J]. Journal of Peking University(Health Sciences), 2023 , 55(5) : 825 -832 . DOI: 10.19723/j.issn.1671-167X.2023.05.008

References

1 Bahadoram S , Davoodi M , Hassanzadeh S , et al. Renal cell carcinoma: An overview of the epidemiology, diagnosis, and treatmen[J]. G Ital Nefrol, 2022, 39 (3): 1- 16.
2 Blute ML , Leibovich BC , Lohse CM , et al. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus[J]. BJU Int, 2004, 94 (1): 33- 41.
3 Reese AC , Whitson JM , Meng MV . Natural history of untreated renal cell carcinoma with venous tumor thrombus[J]. Urol Oncol, 2013, 31 (7): 1305- 1309.
4 Yang L , Fu B . Nomograms for predicting overall survival and cancer-specific survival of patients with renal cell carcinoma and venous tumor thrombus: A population-based study[J]. Front Surg, 2022, 9, 929885.
5 Dufresne P , Moore L , Tardif PA , et al. Impact of trauma centre designation level on outcomes following hemorrhagic shock: A multicentre cohort study[J]. Can J Surg, 2017, 60 (1): 45- 52.
6 Zheng D , Pan H , Cui X , et al. Preliminary study on changes in coagulation function and component transfusion time in patients with massive hemorrhage[J]. Transfus Apher Sci, 2011, 44 (1): 15- 19.
7 Liu Z , Zhao X , Zhang HX , et al. Peking University Third Hospital score: A comprehensive system to predict intra-operative blood loss in radical nephrectomy and thrombectomy[J]. Chin Med J (Engl), 2020, 133 (10): 1166- 1174.
8 中华医学会泌尿外科学分会中国肾癌联盟, 中国肾癌伴下腔静脉癌栓诊疗协作组. 肾癌伴静脉癌栓诊治专家共识[J]. 中华泌尿外科杂志, 2018, 39 (12): 881- 884.
9 刘茁, 马潞林, 田晓军, 等. 根治性肾切除术+下腔静脉癌栓取出术治疗Mayo 0~Ⅳ级下腔静脉癌栓的临床经验[J]. 中华泌尿外科杂志, 2017, 38 (11): 842- 847.
10 Beck AD . Renal cell carcinoma involving the inferior vena cava: Radiologic evaluation and surgical management[J]. J Urol, 1977, 118 (4): 533- 537.
11 史沛清, 高治中. 肾癌并发肾静脉及下腔静脉瘤栓的诊断和治疗四例分析[J]. 中华肿瘤杂志, 1985, 7 (6): 425.
12 Fergany AF , Gill IS , Schweizer DK , et al. Laparoscopic radical nephrectomy with level Ⅱ vena caval thrombectomy: Survival porcine study[J]. J Urol, 2002, 168 (6): 2629- 2631.
13 Romero FR , Muntener M , Bagga HS , et al. Pure laparoscopic radical nephrectomy with level Ⅱ vena caval thrombectomy[J]. Urology, 2006, 68 (5): 1112- 1124.
14 Xu B , Zhao Q , Jin J , et al. Laparoscopic versus open surgery for renal masses with infrahepatic tumor thrombus: The largest series of retroperitoneal experience from China[J]. J Endourol, 2014, 28 (2): 201- 207.
15 Liu Z , Zhao X , Ge L , et al. Completely laparoscopic versus open radical nephrectomy and infrahepatic tumor thrombectomy: Comparison of surgical complexity and prognosis[J]. Asian J Surg, 2021, 44 (4): 641- 648.
16 Abaza R . Initial series of robotic radical nephrectomy with vena caval tumor thrombectomy[J]. Eur Urol, 2011, 59 (4): 652- 656.
17 王林辉, 叶华茂, 吴震杰, 等. 中国首例达芬奇机器人辅助全腔镜下右肾癌根治切除联合腔静脉Ⅱ级癌栓取出术[J]. 第二军医大学学报, 2014, 35 (7): 763- 768.
18 Rose KM , Navaratnam AK , Faraj KS , et al. Comparison of open and robot assisted radical nephrectomy with level Ⅰ and Ⅱ inferior vena cava tumor thrombus: The Mayo Clinic experience[J]. Urology, 2020, 136, 152- 157.
19 Liu Z , Zhu GD , Zhao X , et al. A modified surgical technique of shortening renal ischemia time in left renal cancer patients with Mayo level Ⅱ-Ⅳ tumor thrombus[J]. BMC Surg, 2020, 20 (1): 120.
20 Chopra S , Simone G , Metcalfe C , et al. Robot-assisted level Ⅱ-Ⅲ inferior vena cava tumor thrombectomy: Step-by-step technique and 1-year outcomes[J]. Eur Urol, 2017, 72 (2): 267- 274.
21 Wang B , Huang Q , Liu K , et al. Robot-assisted level Ⅲ-Ⅳ inferior vena cava thrombectomy: Initial series with step-by-step procedures and 1-year outcomes[J]. Eur Urol, 2020, 78 (1): 77- 86.
22 赵勋, 李丽伟, 马潞林, 等. 根治性肾切除术及下腔静脉癌栓取出术治疗Mayo Ⅳ级下腔静脉癌栓的手术技术及临床经验[J]. 现代泌尿外科杂志, 2019, 24 (8): 639- 644.
23 Wang GJ , Carpenter JP , Fairman RM , et al. Single-center experience of caval thrombectomy in patients with renal cell carcinoma with tumor thrombus extension into the inferior vena cava[J]. Vasc Endovascular Surg, 2008, 42 (4): 335- 340.
24 Shao P , Li J , Qin C , et al. Laparoscopic radical nephrectomy and inferior vena cava thrombectomy in the treatment of renal cell carcinoma[J]. Eur Urol, 2015, 68 (1): 115- 122.
25 Shen D , Wang H , Wang C , et al. Cumulative sum analysis of the operator learning curve for robot-assisted Mayo Clinic level Ⅰ-Ⅳ inferior vena cava thrombectomy associated with renal carcinoma: A Study of 120 cases at a single center[J]. Med Sci Monit, 2020, 26, e922987.
26 Quencer KB , Friedman T , Sheth R , et al. Tumor thrombus: Incidence, imaging, prognosis and treatment[J]. Cardiovasc Diagn Ther, 2017, 7 (Suppl 3): S165- S177.
27 Psutka SP , Boorjian SA , Thompson RH , et al. Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus[J]. BJU Int, 2015, 116 (3): 388- 396.
28 李丽伟, 刘茁, 王淑敏, 等. 肾癌伴下腔静脉瘤栓合并血栓的多种影像学比较[J]. 北京大学学报(医学版), 2019, 51 (4): 678- 683.
29 Ayyathurai R , Garcia-Roig M , Gorin MA , et al. Bland thrombus association with tumour thrombus in renal cell carcinoma: Analysis of surgical significance and role of inferior vena caval interruption[J]. BJU Int, 2012, 110 (11 Pt B): 449- 455.
30 孟颖, 谭石, 王淑敏, 等. 超声及超声造影在肾细胞癌伴下腔静脉瘤栓合并血栓诊断中的价值[J]. 中华医学超声杂志(电子版), 2020, 17 (8): 728- 736.
31 Shirodkar SP , Ciancio G , Soloway MS . Vascular stapling of the inferior vena cava: Further refinement of techniques for the excision of extensive renal cell carcinoma with unresectable vena-caval involvement[J]. Urology, 2009, 74 (4): 846- 850.
32 杜松良, 黄庆波, 张旭, 等. 下腔静脉瘤栓切除术中下腔静脉离断的术前决策及影响因素分析[J]. 微创泌尿外科杂志, 2018, 7 (4): 230- 234.
Outlines

/